CD99 is known to be involved in the regulation of cell-cell adhesion. However, it remains unclear whether CD99 controls cell-extracellular matrix adhesion. In this study, the effects of CD99 activation on cell-extracellular matrix adhesion were investigated. It was found that engagement of CD99 with the stimulating antibody YG32 downregulated the adhesion of MCF-7 cells to fibronectin, laminin and collagen IV in a dose-dependent manner. The CD99 effect on cell-ECM adhesion was inhibited by overexpression of the dominant negative form of CD99 or CD99 siRNA transfection. Treatment of cells with Mn 2+ or by β1 integrin-stimulating antibody restored the inhibitory effect of CD99 on cell-ECM adhesion. Cross-linking CD99 inactivated β1 integrin through conformational change. CD99 activation caused dephosphorylation at Tyr-397 in FAK, which was restored by the β1 stimulating antibody. Taken together, these results provide the first evidence that CD99 inhibits cell-extracellular matrix adhesion by suppressing β1 integrin affinity. [BMB reports 2012; 45(3): 159-164]
INTRODUCTION
The regulation of β1 integrin activity through "inside-out signaling" plays a significant role in a variety of cell behaviors, in both pathological and normal physiology (1, 2). Several receptor molecules have been previously shown to regulate β1 integrin activity; these include CD47, CD98 and the tetraspan family (TM4SF) of receptors, which includes CD9, CD81 and CD151. It was found that the binding of thrombospondin-1 (TSP 1) or peptides from TSP 1 to CD47 led to activation of β1 integrin in vascular smooth muscle cells (3). CD98 activation induced not only conformational changes of β1 integrin but also changes in its surface expression and clustering (4, 5). It has been suggested that CD9 enhances cell motility to fibronectin by activating β1 integrin via a PI-3 kinase-dependent pathway (6). CD81 and CD151 form a stable complex with β1 integrin, which potentiates the ligand-binding activity of the integrin through sustaining its activated conformation (7, 8) . On the other hand, chemorepulsive signal receptors such as semaphorins and ephrins negatively regulate β1 integrin; for example, previous study showed that activation of Plexin-B1 by Semaphorin 4D inhibited β1 integrin-mediated adhesion via inactivating R-Ras (9, 10). It was also shown that EphA2 activation suppressed integrin mediated cell adhesion, spreading and migration by inducing conformational change of β1 integrin (11). The human CD99 protein is a 32 kDa type I transmembrane glycoprotein which is broadly expressed on many cell types, but which is abundant on lymphocytes and on several tumors including Ewing's sarcoma (12) (13) (14) . The CD99 protein has been implicated in various cellular processes, including apoptosis, vesicular protein transport, thymocyte differentiation, and leucocyte diapedesis (15) (16) (17) (18) (19) . Several lines of evidence indicate that CD99 may be involved in the regulation of cell-cell adhesion as well. For example, cross-linking of CD99 molecules with a monoclonal antibody was shown to induce homotypic aggregation of lymphocytes through up-regulation of LFA-1 (αLβ2 integrin) activity and expression (13, 20) . In addition, CD99 engagement induced the adhesion of T lymphocytes to VCAM-1-expressing endothelial cell monolayers by stimulating α4β1 (21, 22). These results led us to hypothesize that CD99 could be involved in the regulation of cell-ECM interaction as well. This study provides evidence that the activation of CD99 drastically reduces the adhesion of MCF-7 cells to fibronectin, laminin, and collagen IV by attenuating β1 integrin affinity.
RESULTS

CD99 engagement inhibits β1 integrin-mediated cell-ECM adhesion
To investigate whether CD99 activation leads to any change in adhesion of MCF-7 cells to ECM, we treated MCF-7 cells with http://bmbreports.org Binding of the anti-human CD99 monoclonal antibody against CD99 molecules expressed on the cell surface was induced and the cells were then stained with an FITC-conjugated anti-mouse IgG antibody. (B) MCF-7 cells were treated with the anti-CD99 monoclonal antibody YG32 and goat anti-mouse IgG (whole molecule). 1 hour after incubation, the number of MCF-7 cells attached to fibronectin, laminin, collagen IV and poly-L-lysine were determined as described in the "Materials and Methods" section. (C) MCF-7 cells were incubated with increasing amounts of the anti-CD99 monoclonal antibody and then an adhesion assay was performed. Results were replicated in three independent experiments. A significant difference from the control is shown by asterisks as follows: *P ＜ 0.05; **P ＜ 0.01, ***P ＜ 0.001. Lines indicate additional statistical comparisons. CD99 activating mAb YG32 (23) and anti-mouse IgG as a secondary Ab for one hour and then allowed adherence to fibronectin, laminin, collagen V or poly-L-lysine (PLL) coated plates in the absence of serum. As shown in Fig. 1A , CD99 is abundantly expressed in MCF-7 cells. Cross-linking CD99 decreased cell adhesion to fibronectin, laminin, and collagen IV (Fig. 1B) . In contrast, adhesion to poly-L-lysine, which does not engage integrins, was not affected by CD99 activation. When MCF-7 cells were incubated in the presence of increasing concentrations of YG32, a dose-dependent decrease in adhesion was seen (Fig. 1C) . When the MCF-7 cells were treated with mouse IgG1 and anti-mouse IgG, the level of cell adhesion to ECM proteins was similar to that of untreated MCF-7 cells.
Loss of CD99 function diminishes the inhibitory effect of CD99 on cell adhesion
To confirm whether or not the effect of CD99 engagement on the adhesion of MCF-7 cells to ECM is mediated by CD99 molecules on the cells, we obtained a dominant-negative (DN) CD99-EGFP fusion construct. Dominant negative CD99-EGFP chimeric molecules contain the extracellular and transmembrane domain of CD99 fused to EGFP. After MCF-7 cells were transfected with the DN CD99-EGFP fusion construct, stably transfected MCF-7 cells showing high level of CD99 were selected (Fig. 2A) . We confirmed the expression of DN CD99-EGFP using Western blot analysis and confocal microscopy ( Fig. 2B and C) . Fig. 2D shows that overexpression of dominant negative CD99 reversed the inhibitory effect on CD99 on the cell-ECM adhesion. To further examine whether CD99 activation inhibits cell-ECM adhesion, we transiently transfected MCF-7 cells with siRNA for the CD99 gene and then treated them with anti-CD99 mAb YG32. Western blot analysis revealed a decrease in CD99 expression in the cells that had been transiently transfected with CD99 siRNA, compared to the control cells transfected with control siRNA (Fig. 2E ). As shown in Fig. 2F , treatment with CD99 siRNAs inhibited the CD99-mediated suppression of adhesion of MCF-7 cells to fibronectin. Taken together, these results indicate that antibody-induced CD99 signaling down-regulates adhesion of MCF-7 cells to ECM molecules through CD99.
Cross-linking CD99 induces conformational change of β1 integrin
To examine whether inhibition of cell adhesion by CD99 signaling derives from conformational changes in integrin, we treated MCF-7 cells with Mn 2+ that converts integrin into an active conformation (24), before stimulating cells with CD99 mAb. Fig. 3A shows that the addition of Mn 2+ reversed the inhibitory effects of CD99 in a concentration-dependent manner. Since the common ligand for fibronectin, laminin, and collagen IV is β1 integrin, we investigated whether or not treatment of cells with the β1 integrin-stimulating antibody B44 reverses CD99's effect on the adhesion of cells to fibronectin (24). As shown in Fig. 3B , activation of β1 integrin diminished the inhibitory effect of anti-CD99 mAb on cell-ECM adhesion in a dose-dependent manner. In fact, Fig. 3C shows that the CD99 monoclonal antibody YG32 converted β1 integrins to an inactive conformation in a dose and temperature-dependent manner (25). These results indicate that CD99 activation converted β1 integrins into an inactive conformation, thereby decreasing cell binding to extracellular matrix. Next, we determined whether CD99-induced inactivation of β1 integrin leads to a dephosphorylation of focal adhesion kinase (FAK), which is a key regulatory molecule in the downstream signaling events that occur after integrin activation (26). The effect of CD99 activation on the phosphorylation status of FAK in MCF-7 cell attached to the matrix was examined by
